期刊文献+

Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis 被引量:8

Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis
下载PDF
导出
摘要 AIM:To investigate the adipokine levels of leptin,adiponectin,resistin,visfatin,retinol-binding protein 4(RBP4),apelin in alcoholic liver cirrhosis(ALC).METHODS:Forty non-diabetic ALC patients[median age:59 years,males:35(87.5%),Child-Pugh(CP)score:median 7(5-12),CP A/B/C:18/10/12,Model for End-stage Liver Disease(MELD):median 10(6-25),follow-up:median 32.5 mo(10-43)]were prospectively included.The serum adipokine levels were estimated in duplicate by ELISA.Somatometric characteristics were assessed with tetrapolar bioelectrical impedance analysis.Pearson’s rank correlation coefficient was used to assess possible associations with adipokine levels.Univariate and multivariate Cox regression analysis was used to determine independent predictors for overallsurvival.RESULTS:Body mass index:median 25.9(range:20.1-39.3),fat:23.4%(7.6-42.1),fat mass:17.8(5.49-45.4),free fat mass:56.1(39.6-74.4),total body water(TBW):40.6(29.8-58.8).Leptin and visfatin levels were positively associated with fat mass(P<0.001/P=0.027,respectively)and RBP4 with TBW(P=0.025).Median adiponectin levels were significantly higher in CPC compared to CPA(CPA:7.99±14.07,CPB:7.66±3.48,CPC:25.73±26.8,P=0.04),whereas median RBP4 and apelin levels decreased across the spectrum of disease severity(P=0.006/P=0.034,respectively).Following adjustment for fat mass,visfatin and adiponectin levels were significantly increased from CPA to CPC(both P<0.001),whereas an inverse correlation was observed for both RBP4 and apelin(both P<0.001).In the multivariate Cox regression analysis,only MELD had an independent association with overall survival(HR=1.53,95%CI:1.05-2.32;P=0.029).CONCLUSION:Adipokines are associated with deteriorating liver function in a complex manner in patients with alcoholic liver cirrhosis. AIM:To investigate the adipokine levels of leptin,adiponectin,resistin,visfatin,retinol-binding protein 4(RBP4),apelin in alcoholic liver cirrhosis(ALC).METHODS:Forty non-diabetic ALC patients[median age:59 years,males:35(87.5%),Child-Pugh(CP)score:median 7(5-12),CP A/B/C:18/10/12,Model for End-stage Liver Disease(MELD):median 10(6-25),follow-up:median 32.5 mo(10-43)]were prospectively included.The serum adipokine levels were estimated in duplicate by ELISA.Somatometric characteristics were assessed with tetrapolar bioelectrical impedance analysis.Pearson’s rank correlation coefficient was used to assess possible associations with adipokine levels.Univariate and multivariate Cox regression analysis was used to determine independent predictors for overallsurvival.RESULTS:Body mass index:median 25.9(range:20.1-39.3),fat:23.4%(7.6-42.1),fat mass:17.8(5.49-45.4),free fat mass:56.1(39.6-74.4),total body water(TBW):40.6(29.8-58.8).Leptin and visfatin levels were positively associated with fat mass(P<0.001/P=0.027,respectively)and RBP4 with TBW(P=0.025).Median adiponectin levels were significantly higher in CPC compared to CPA(CPA:7.99±14.07,CPB:7.66±3.48,CPC:25.73±26.8,P=0.04),whereas median RBP4 and apelin levels decreased across the spectrum of disease severity(P=0.006/P=0.034,respectively).Following adjustment for fat mass,visfatin and adiponectin levels were significantly increased from CPA to CPC(both P<0.001),whereas an inverse correlation was observed for both RBP4 and apelin(both P<0.001).In the multivariate Cox regression analysis,only MELD had an independent association with overall survival(HR=1.53,95%CI:1.05-2.32;P=0.029).CONCLUSION:Adipokines are associated with deteriorating liver function in a complex manner in patients with alcoholic liver cirrhosis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第10期3020-3029,共10页 世界胃肠病学杂志(英文版)
关键词 ADIPOKINES ADIPONECTIN CIRRHOSIS LEPTIN RESISTIN Adipokines Adiponectin Cirrhosis Leptin Resistin
  • 相关文献

参考文献20

  • 1Emmanuel A Tsochatzis,Jaime Bosch,Andrew K Burroughs.Liver cirrhosis[J]. The Lancet . 2014
  • 2Erica Novo,Stefania Cannito,Claudia Paternostro,Claudia Bocca,Antonella Miglietta,Maurizio Parola.Cellular and molecular mechanisms in liver fibrogenesis[J]. Archives of Biochemistry and Biophysics . 2013
  • 3Wei Zhang,Minghui Niu,Kunfeng Yan,Xuguang Zhai,Qian Zhou,Li Zhang,Yajun Zhou.Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells[J]. International Journal of Biochemistry and Cell Biology . 2013 (3)
  • 4Alejandro Forner,María E. Reig,Carlos Rodriguez de Lope,Jordi Bruix.Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects[J].Semin Liver Dis.2010(01)
  • 5Emmanuel Tsochatzis,George V. Papatheodoridis,Emilia Hadziyannis,Anastasia Georgiou,Georgia Kafiri,Dina G. Tiniakos,Emanuel K. Manesis,Athanasios J. Archimandritis.Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity[J]. Scandinavian Journal of Gastroenterology . 2008 (9)
  • 6Andrew D. Clouston,Julie R. Jonsson,Elizabeth E. Powell.Steatosis as a Cofactor in Other Liver Diseases: Hepatitis C Virus, Alcohol, Hemochromatosis, and Others[J]. Clinics in Liver Disease . 2007 (1)
  • 7S.KASER,A.MOSCHEN,A.KASER,O.LUDWICZEK,C. F.EBENBICHLER,W.VOGEL,W.JASCHKE,J. R.PATSCH,H.TILG.Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis[J]. Journal of Internal Medicine . 2005 (3)
  • 8Anna Mae Diehl.Obesity and alcoholic liver disease[J]. Alcohol . 2005 (1)
  • 9Frank Tacke,Torsten Wüstefeld,Rüdiger Horn,Tom Luedde,Annavarapu Srinivas Rao,Michael P. Manns,Christian Trautwein,Georg Brabant.High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo[J]. Journal of Hepatology . 2005 (5)
  • 10Paul Angulo,Laura M. Alba,Lydia M. Petrovic,Leon A. Adams,Keith D. Lindor,Michael D. Jensen.Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease[J]. Journal of Hepatology . 2004 (6)

共引文献12

同被引文献21

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部